November was a great month for the markets. In fact, it was one of the best on record. U.S. markets were up by double digits, as were most markets around the world. We saw new all-time highs here, and even fixed income had a good month. From an investor’s point of view, things looked not just good but great—and clearly markets expect even better times ahead. But do they have it right? Let’s take a closer look.

November was a very strong month for the stock markets, with most up by double digits. With good news on vaccines and the resolution of the presidential election, investors gained confidence. But medical risks remain, and the economic risks rose. Layoffs increased, and consumer confidence declined. Business confidence remained high but has pulled back.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, we’ve seen significant improvements. Case growth has shown signs of topping, indicating the third wave may be about to crest. Further, three vaccines were announced as effective and safe in the past two weeks. While the pandemic is still in force and there is a potential risk from Thanksgiving gatherings, the trends may be starting to reverse.

This weekly update is appearing a couple of days early, due to Thanksgiving. We will go back to the regular Thursday schedule next week. I hope everyone has a terrific holiday. As always, I am grateful for all of you my friends and readers.

Right now, the headlines are dominated by pandemic news, with the number of new cases continuing to hit all-time highs. But there is also growing worry that in addition to the tragic medical damage, we might see the economic recovery roll over as well. While this is a legitimate fear, the data is showing something different—that we may well be close to the end of the recession and back into a sustainable expansion.

As expected, the medical news continues to get worse. New infections hit all-time highs last week as the third wave of the pandemic has accelerated around the country. Case growth in many states remains at levels that threaten health care systems.

My colleague Sam Millette, senior investment research analyst on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Market Risk Update. Thanks for the assist, Sam!

My colleague Sam Millette, senior investment research analyst on Commonwealth’s Investment Management and Research team, plays a key role in putting together the Economic and Market Risk Factor Updates. We are now working on updating the format, and you will see some changes this month and in coming months. Thanks for the great work, Sam!

The economy showed continued growth in October; however, the indicators we track in this piece showed varied results. Despite the mixed nature of the reports, the continued signs of economic growth during the month were encouraging, given the uncertainty created by rising coronavirus case counts and the election. The October jobs report was a highlight, as both the number of new jobs added and the unemployment rate came in better than expected. Business and consumer confidence, however, declined slightly during the month, though they still remain well off the lows. Overall, this was a month that showed continued improvement, as well as the ongoing risk the pandemic represents to the recovery as we head into the end of the year.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, case growth continues to accelerate, and new cases have reached all-time highs. This is something we need to watch, as the third wave is at a level where the national risks are material.

Yesterday I appeared on Yahoo Finance’s The Final Round to discuss the impact of the coronavirus vaccine news on the market. Listen in to hear more.